GlassScriptPhysician profile
Mehwish Khan
NPI 1174721385
$3,149.51
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $770 · 2020: $488 · 2021: $272 · 2022: $453 · 2023: $779 · 2024: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,166.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,013.12 | 2019-2024 | Prolia, Evenity, Enbrel |
| Horizon Therapeutics Plc | $317.85 | 2019-2020 | |
| Novo Nordisk INC | $276.76 | 2021-2024 | Ozempic, Rybelsus |
| Silk Road Medical, INC. | $152.38 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Mallinckrodt Hospital Products INC. | $144.29 | 2020-2023 | Acthar |
| Ucb, INC. | $133.43 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $108.46 | 2020-2023 | Saphnelo |
| Celgene Corporation | $107.77 | 2019 | |
| Lilly USA, LLC | $99.03 | 2019-2023 | Mounjaro |
| Sanofi Pasteur INC. | $96.88 | 2019 | |
| Pfizer INC. | $93.82 | 2019-2024 | |
| Janssen Biotech, INC. | $89.98 | 2020-2022 | |
| Radius Health, INC. | $79.10 | 2019-2022 | |
| Exact Sciences Corporation | $70.13 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $66.09 | 2023-2024 | Arexvy, Shingrix, Bexsero |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $55.62 | 2024 | Nexletol |
| Abbvie INC. | $52.95 | 2019-2023 | |
| Astellas Pharma US INC | $47.53 | 2019 | |
| Hikma Pharmaceuticals USA | $25.77 | 2020 | |
| Dynavax Technologies Corporation | $23.71 | 2023 | Heplisav-B |
| Ani Pharmaceuticals, INC. | $20.96 | 2023 | Purified Cortrophin Gel |
| Ibsa Pharma INC. | $20.43 | 2024 | Licart, Tirosint |
| Inari Medical, INC. | $19.20 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biohaven Pharmaceuticals, INC. | $17.77 | 2021 | |
| Hologic Sales and Service, LLC | $16.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehwish Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.